These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 31119725)

  • 61. Impact of dosing schedule on uptake of neuroprotective magnesium sulfate.
    Cuff RD; Sullivan SA; Chang EY
    J Matern Fetal Neonatal Med; 2020 Mar; 33(6):982-986. PubMed ID: 30122071
    [No Abstract]   [Full Text] [Related]  

  • 62. Magnesium sulfate for neuroprotection in the setting of chorioamnionitis.
    Edwards JM; Edwards LE; Swamy GK; Grotegut CA
    J Matern Fetal Neonatal Med; 2018 May; 31(9):1156-1160. PubMed ID: 28395549
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Timing of administration of antenatal magnesium sulfate and umbilical cord blood magnesium levels in preterm babies.
    Reynolds A; Slattery S; Byrne S; Neary E; Müllers S; Kent E; Malone FD; El-Khuffash A; McGarvey C; Hayes BC
    J Matern Fetal Neonatal Med; 2019 Mar; 32(6):1014-1019. PubMed ID: 29082790
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Re: Antenatal magnesium sulphate for the prevention of cerebral palsy in infants born preterm: a double-blind, randomised, placebo-controlled, multi-centre trial: At which gestational ages should magnesium sulphate be given to women at risk of preterm birth?
    Larsen ML; Krebs L; Rackauskaite G; Hoei-Hansen CE; Greisen G
    BJOG; 2020 Sep; 127(10):1295-1296. PubMed ID: 32394601
    [No Abstract]   [Full Text] [Related]  

  • 65. Different magnesium sulphate regimens for neuroprotection of the fetus for women at risk of preterm birth.
    Bain E; Middleton P; Crowther CA
    Cochrane Database Syst Rev; 2012 Feb; 2012(2):CD009302. PubMed ID: 22336863
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Is the pharmacological use of intravenous magnesium before preterm cerebroprotective or deleterious for premature infants? Possible importance of the use of magnesium sulphate.
    Durlach J; Bac P; Bara M; Guiet-Bara A
    Magnes Res; 1998 Dec; 11(4):323-5. PubMed ID: 9884990
    [No Abstract]   [Full Text] [Related]  

  • 67. Use and attitudes of obstetricians toward 3 high-risk interventions in MFMU Network hospitals.
    Bousleiman SZ; Rice MM; Moss J; Todd A; Rincon M; Mallett G; Milluzzi C; Allard D; Dorman K; Ortiz F; Johnson F; Reed P; Tolivaisa S;
    Am J Obstet Gynecol; 2015 Sep; 213(3):398.e1-11. PubMed ID: 25957021
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Antenatal magnesium sulfate and neuroprotection.
    Doyle LW
    Curr Opin Pediatr; 2012 Apr; 24(2):154-9. PubMed ID: 22227787
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Magnesium sulphate for preventing preterm birth in threatened preterm labour.
    Crowther CA; Hiller JE; Doyle LW
    Cochrane Database Syst Rev; 2002; (4):CD001060. PubMed ID: 12519550
    [TBL] [Abstract][Full Text] [Related]  

  • 70. What gestation cut-off should be used for magnesium sulfate treatment of women threatening to deliver preterm?
    Knight DB; Gardener GJ
    Am J Obstet Gynecol; 2010 Mar; 202(3):e9; author reply e9-10. PubMed ID: 19889392
    [No Abstract]   [Full Text] [Related]  

  • 71. Maternal and fetal serum concentrations of magnesium after administration of a 6-g bolus dose of magnesium sulfate (MgSO
    Jonsdotter A; Rocha-Ferreira E; Hagberg H; Carlsson Y
    Acta Obstet Gynecol Scand; 2022 Aug; 101(8):856-861. PubMed ID: 35501953
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Cerebral Palsy in Very Preterm Infants: A Nine-Year Prospective Study in a French Population-Based Tertiary Center.
    Chollat C; Bertrand E; Petit-Ledo A; de Vansay C; Voisin C; Dabaj I; Gillibert A; Marret S;
    J Pediatr; 2021 Oct; 237():183-189.e6. PubMed ID: 34144033
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Magnesium sulphate treatment decreases the risk of cerebral palsy after preterm birth].
    Wolf HT; Henriksen TB; Larsen ML; Pinborg A; Hegaard HK; Brok JS; Huusom LD
    Ugeskr Laeger; 2020 Nov; 182(47):. PubMed ID: 33215580
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Preterm premature rupture of membranes.
    Meller CH; Carducci ME; Ceriani Cernadas JM; Otaño L
    Arch Argent Pediatr; 2018 Aug; 116(4):e575-e581. PubMed ID: 30016035
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Magnesium for fetal neuroprotection.
    Reeves SA; Gibbs RS; Clark SL
    Am J Obstet Gynecol; 2011 Mar; 204(3):202.e1-4. PubMed ID: 21376159
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Influence of maternal magnesium sulphate and ritodrine treatment on the neonate: a study with six-month follow-up.
    Rantonen T; Ekblad U; Grönlund J; Rikalainen H; Välimäki I; Kero P
    Acta Paediatr; 1999 Oct; 88(10):1142-6. PubMed ID: 10565464
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Prolonged latency of preterm prelabour rupture of membranes and neurodevelopmental outcomes: a secondary analysis.
    Drassinower D; Friedman AM; Običan SG; Levin H; Gyamfi-Bannerman C
    BJOG; 2016 Sep; 123(10):1629-35. PubMed ID: 27245741
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Antenatal magnesium sulphate and adverse neonatal outcomes: A systematic review and meta-analysis.
    Shepherd E; Salam RA; Manhas D; Synnes A; Middleton P; Makrides M; Crowther CA
    PLoS Med; 2019 Dec; 16(12):e1002988. PubMed ID: 31809499
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Magnesium sulfate, chorioamnionitis, and neurodevelopment after preterm birth.
    Kamyar M; Manuck TA; Stoddard GJ; Varner MW; Clark E
    BJOG; 2016 Jun; 123(7):1161-6. PubMed ID: 26036660
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Committee Opinion No 652: Magnesium Sulfate Use in Obstetrics.
    Obstet Gynecol; 2016 Jan; 127(1):e52-e53. PubMed ID: 26695587
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.